PLx Pharma

PLXP NASDAQ
5.50
-0.37
-6.30%
Closed 16:00 08/16 EDT
Open
6.24
Prev Close
5.87
High
6.24
Low
5.50
Volume
1.04K
Avg Vol (3M)
10.46K
52 Week High
7.41
52 Week Low
1.000
% Turnover
0.01%
Market Cap
49.74M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers PLx Pharma PLXP stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen, PL1200 Ibuprofen Capsules, 200 mg.
MORE >

Recently

Name
Price
%Change